Tech Company Financing Transactions

Relievant Medsystems Funding Round

Relievant Medsystems, operating out of Minneapolis, scored $30 million from New Enterprise Associates, Canaan Partners and Emergent Medical Partners.

Transaction Overview

Company Name
Relievant Medsystems
Announced On
3/28/2012
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series D
Investors

New Enterprise Associates (Lead Investor) (Justin Klein)

Canaan Partners (Brent Ahrens)

Emergent Medical Partners

Morgenthaler Ventures (Jason Lettmann)

ONSET Ventures (Leslie Bottorff)

Proceeds Purpose
Proceeds from this financing will enable Relievant to accelerate execution of our landmark SMART Clinical Trial and to conduct additional clinical studies for the Intracept Ablation System. These studies are key drivers for our plan to continue advancing the utility of basivertebral nerve ablation for isolated axial low back pain and to successfully commercialize Intracept worldwide.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
8500 Normandale Lakes Blvd. 2150
Minneapolis, MN 55437
USA
Phone
(650) 368-1000
Website
www.relievant.com
Email Address
[email protected]
Overview
Relievant MedSystems is a medical device company developing novel products to treat lower back pain using a minimally invasive therapeutic approach. The company was founded in 2004 and is headquartered in San Francisco, California.
Profile
Relievant Medsystems LinkedIn Company Profile
Social Media
Relievant Medsystems Company Twitter Account
Company News
Relievant Medsystems News
Facebook
Relievant Medsystems on Facebook
YouTube
Relievant Medsystems on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Kevin Hykes
  Kevin Hykes LinkedIn Profile  Kevin Hykes Twitter Account  Kevin Hykes News  Kevin Hykes on Facebook
Chief Financial Officer
Chris Geyen
  Chris Geyen LinkedIn Profile  Chris Geyen Twitter Account  Chris Geyen News  Chris Geyen on Facebook
Chief Medical Officer
Ray Baker
  Ray Baker LinkedIn Profile  Ray Baker Twitter Account  Ray Baker News  Ray Baker on Facebook
Chief Operating Officer
Alex DiNello
  Alex DiNello LinkedIn Profile  Alex DiNello Twitter Account  Alex DiNello News  Alex DiNello on Facebook
Vice President
Mary Hailey
  Mary Hailey LinkedIn Profile  Mary Hailey Twitter Account  Mary Hailey News  Mary Hailey on Facebook
VP - R & D
Brian Donovan
  Brian Donovan LinkedIn Profile  Brian Donovan Twitter Account  Brian Donovan News  Brian Donovan on Facebook
VP - Regulatory Affairs
Diane Sahr
  Diane Sahr LinkedIn Profile  Diane Sahr Twitter Account  Diane Sahr News  Diane Sahr on Facebook
VP - Sales
Kirk Ellis
  Kirk Ellis LinkedIn Profile  Kirk Ellis Twitter Account  Kirk Ellis News  Kirk Ellis on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/28/2012: Quarterly venture capital transaction
Next: 3/28/2012: Mob Science venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.